LAUSR

outcomes in adults with pediatric-onset morphea. Arch Dermatol 2010; 146: 1044–1045. 4 Amy de la Bret eque M, Rybojad M, Cordoliani F, et al. Relapse of severe forms of adult morphea after oral corticosteroid treatment. J Eur Acad Dermatol Venereol 2013; 27: 1190–1191. 5 Vasquez R, Jabbar A, Khan F, et al. Recurrence of morphea after successful ultraviolet al phototherapy: a cohort study. J Am Acad Dermatol 2014; 70: 481–488. 6 Mirsky L, Chakkittakandiyil A, Laxer RM, et al. Relapse after systemic treatment in paediatric morphoea. Br J Dermatol 2012; 166: 443–445. 7 Martini G, Fadanelli G, Agazzi A, et al. Disease course and longterm outcome of juvenile localized scleroderma: experience from a single pediatric rheumatology Centre and literature review. Autoimmun Rev 2018; 17: 727–734. 8 Fett N, Werth VP. Update on morphea: part II. Outcome measures and treatment. J Am Acad Dermatol 2011; 64: 231– 242; quiz 243–4. 9 Zwischenberger BA, Jacobe HT. A systematic review of morphea treatments and therapeutic algorithm. J Am Acad Dermatol 2011; 65: 925–941.